Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Up 0.1%
Tue, 12 Nov 14:0

INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Up 0.1%Image source: phive2015/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has plunged 5% and is presently trading at Rs 447.2.

Meanwhile, the BSE HEALTHCARE index is at 43,497.7 (up 0.1%).

Among the top losers in the BSE HEALTHCARE index today are Glenmark Pharma (down 2.5%) and SUVEN PHARMACEUTICALS (down 2.2%).

ASTRAZENECA PHARMA (up 4.0%) and ERIS LIFESCIENCES (up 3.5%) are among the top gainers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 197.9 to Rs 447.2, registering a gain of Rs 249.3 (up 126.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,646.0 to 43,497.7, registering a gain of 51.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 205.7%), SUVEN PHARMACEUTICALS (up 114.1%) and Glenmark Pharma (up 102.9%).

For Investors: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 78,854.1 (down 0.8%).

The top losers among the BSE Sensex today are HDFC Bank (down 2.6%) and Asian Paints (down 2.6%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 23,947.3 (down 0.8%). HDFC Bank and Asian Paints are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,975.6 to 78,854.1, registering a gain of 13,878.5 points (up 21.4%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 29.1% YoY to Rs 424 million for the quarter ended September 2024, compared to a profit of Rs 329 million a year ago. Net sales rose 10.4% to Rs 3,498 million during the period as against Rs 3,170 million in July-September 2023.

For the year ended March 2024, INDRAPRASTHA MEDICAL reported 43.9% increase in net profit to Rs 1,240 million compared to net profit of Rs 862 million during FY23. Revenue of the company grew 13.3% to Rs 12,447 million during FY24.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 27.7.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Up 0.1%". Click here!